Bone & Soft Tissue Sarcoma

(949) 722-6237

About
Diagnosis
Treatment
Meet the Team
Support & Resources

Hoag's Bone and Soft Tissue Sarcoma Program offers expert care and compassionate support services centered on patients and their families seeking treatment.

Leading-Edge Sarcoma Care, Close to Home

Sarcoma is a rare and complex family of cancers that develops from connective tissue, with more than 70 known subtypes. These cancers can arise in bone, muscle, cartilage, fat, or other connective tissue, meaning they may occur anywhere in the body—most often in the arms and legs, and less commonly in the retroperitoneum or pelvis. Bone and soft tissue sarcomas affect men and women of all ages, from children to older adults. Each year, about 12,000 new cases are diagnosed in the United States, according to the American Cancer Society. At Hoag, patients with sarcoma have access to comprehensive, specialized care for this rare type of cancer. Our expert team provides advanced surgical options, precise radiation therapy, targeted chemotherapy, and genetic testing to guide personalized treatment plans. Through this multidisciplinary approach, Hoag delivers both leading-edge treatment and compassionate support for patients and families facing sarcoma.

Patient-Centered Care

We understand that a diagnosis of sarcoma can be hard to manage, emotionally, physically and financially. Hoag Family Cancer Institute offers comprehensive support services centered around the patient and their families. From one-on-one counseling, to educational and mind-body-spirit workshops, Hoag Oncology Support Services supports the whole person, and can link you to numerous resources for other types of support.

Sarcoma Nurse Navigator

A clinical nurse navigator serves an important role as facilitator and guide for patients, providing resources, access to clinical providers and answering questions throughout the cancer journey.

Learn More

Bone and Soft Tissue Sarcoma Surgeons

Vivek A. Mehta, MD

Mehta is Neurosurgeon with particular expertise in complex and minimally invasive brain and spine surgery. He is a member of the Hoag Epilepsy Surgery Program at the Pickup Family Neurosciences Institute.  He was raised in Orange County and completed medical school with Alpha Omega Alpha Honors at The Johns Hopkins University School of Medicine. In college, he was named to the USA Today All-Academic First Team as one of the top 20 colleges students in the United States.  After completing medical school, Dr. Mehta completed advanced training in neurosurgery at the University of Southern California under Drs. Michael Apuzzo, Martin Weiss, Gordon McComb and Steven Giannotta and in Epilepsy and Stereotactic Neurosurgery with Dr. Charles Liu.  Prior to joining Hoag, he was on staff at the University of Southern California as an attending neurosurgery at Los Angeles County + USC Medical Center, the nations busiest Level 1 neurosurgery trauma center.  He is an Adjunct Assistant Professor of Clinical Neurosurgery at the USC Keck School of Medicine.

Thomas N. Wang, MD

Thomas Wang, M.D., Ph.D., is a board-certified surgical oncologist with the Hoag Family Cancer Institute and the medical director of the Hoag Melanoma/Advanced Skin Cancer Program. Dr. Wang comes to Hoag after spending the previous 15 years at the University of Alabama at Birmingham (UAB), where he served as a Professor of Surgery at the UAB School of Medicine and Chief of Surgical Oncology for the Birmingham VA Medical Center. He is a recognized author and researcher and has published over 40 original manuscripts in peer- reviewed scientific journals and ten book chapters. He has presented his clinical and basic science research at multiple national and international meetings. Dr. Wang is a graduate of Brown University and attended the Lewis Katz School of Medicine at Temple University. He completed his general surgery residency training at Drexel University College of Medicine/Hahnemann University Hospital and his surgical oncology fellowship at the University of Texas M.D. Anderson Cancer Center. Dr. Wang’s clinical interests include melanoma, soft tissue sarcomas and endocrine surgery. Dr. Wang is an active member on multiple national surgical societies, including the Association for Academic Surgery, the Society of University Surgeons, the American Association of Endocrine Surgeons and the Society of Surgical Oncology. In addition, since 2007, he is a panel member in the National Comprehensive Cancer Network, developing guidelines for the treatment of thyroid cancer.